| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0007 |